Clario

Clario is a leading provider of technology-enabled endpoint services for clinical trials, offering solutions in Cardiac Safety, eCOA, Medical Imaging, Precision Motion, and Respiratory. Founded in 2015 and now part of Thermo Fisher Scientific, the company leverages AI, connected devices, and software to deliver reliable, regulatory-compliant data for sponsors, CROs, and sites. With experience from over 30,000 trials in more than 100 countries, Clario aims to simplify the trial process, improve patient engagement, and accelerate drug development timelines.

Integrated suite of validated clinical trial endpoint technologies including software, connected devices, and AI solutions for Cardiac Safety, eCOA, Medical Imaging, Precision Motion, Respiratory, and Clinical Adjudication.

Clario competes with other large, full-service CROs (like IQVIA, Parexel) developing digital capabilities, specialized eCOA/digital endpoint providers (e.g., Medidata, Science 37, Kaye), and imaging/core lab specialists. Its broad, integrated platform and Thermo Fisher backing are key differentiators.